MedTech 101

Rodney Moses

Discussions about Medical Technology, Pharmaceuticals and popular trends; covering from basic to complex topics in a simplified way to make you understand. Rodney is a Biomedical Engineer and co-inventor working in R&D, ex Johnson & Johnson.

  1. Brain Health as Mainstream as an Eye Test with Lucas Scherdel, Connectome Health

    15 May

    Brain Health as Mainstream as an Eye Test with Lucas Scherdel, Connectome Health

    Send us a Message What if diagnosing depression was as simple as a 15-minute brain scan, no questionnaires, no guesswork, just objective data? That's exactly what Lucas Scherdel and his team at Connectome Health are building. In this episode, Lucas breaks down how their TD-fNIRS technology reads brain activity non-invasively using near-infrared light, how AI turns that raw signal into stable biomarkers, and why the absence of any objective brain test for mental health conditions is one of the most under-discussed problems in medicine today. We also get into the regulatory and investor catch-22 that slows MedTech innovationand Lucas's vision for a world where brain health checks are as routine as visiting the optician. If you work in MedTech, digital health, neuroscience, or you're just curious about where mental healthcare is headed, this one is worth your time. Timestamp: 00:00 – Opening hook: Lucas's vision for mainstream brain sensing 01:33 – Rod's intro and welcome 02:29 – What is Connectome Health? 02:58 – Lucas's background: biomedical sciences, Bayer, WHO 06:48 – How Lucas ended up founding Connectome 10:34 – What does "Connectome" mean? 11:00 – TD-fNIRS explained in layman's terms 12:50 – Why scalable brain measurement has been so hard 16:14 – What does the hardware actually look like? 17:38 – Brain-computer interfaces and the future of prosthetics 19:08 – Challenges: regulatory, manufacturing, scaling 19:37 – Connectome as a software company (platform dependency risk) 22:24 – The inference application layer 23:20 – Business model explained: B2B research tools → future B2C 24:48 – Regulatory landscape and reception from the scientific community 25:17 – Imperial College London healthy population study 26:16 – The investor-regulator catch-22 in MedTech 27:44 – First product: functional brain performance testing 29:34 – Where is mental health tracking headed in 10–15 years? 31:57 – Wrap-up and how to find Lucas (connectome.health / LinkedIn) Support the show Follow or Connect with Rodney Moses: Instagram | LinkedIn | YouTube | Donations Patreon | PayPal

    33 min
  2. 24 Mar

    How to Get Hired in MedTech & Neurotech with Chay Carter

    Send us a Message Ever applied for a job and heard nothing back? You're not alone. 1 in 4 applications right now is a bot, and most companies don't have time to go through 500 applicants. In this episode, medtech recruitment specialist Chay Carter breaks down why the system is broken, what top companies are actually looking for, and how platforms like Reccy Neuro are trying to fix it. Whether you're a student, early career, or looking to break into neurotech or medtech this one's for you. Timestamp: 00:00 Introduction  03:03 Che Carter's background – psychology to banking to neurotech  04:50 Building the Reki Neuro ecosystem – newsletter to job platform  11:01 The neurotech spectrum – implantables, wearables, BCIs  13:15 The bot problem – 1 in 4 applications may be automated  14:20 Newsletter and job board integration  15:24 Candidate matching platform – 70%+ score filtering  19:19 Funding challenges limiting medtech hiring  20:50 Geographic talent hubs – Bay Area, Austin, New York  21:28 Career advice – start at large firms before startups  27:00 The niche ecosystem vision – rebuilding early LinkedIn for medtech  27:20 LinkedIn's decline for focused recruitment  29:28 AI's role in recruitment – helps recruiters, not candidates  31:00 Open access and community growth strategy Links:  Reccy Neuro: https://www.reccy.dev/ Newsletter: https://theneurotechnewsletter.substack.com/ Heres the specific article: https://theneurotechnewsletter.substack.com/p/the-reemergence-of-eeg-why-the-brain Support the show Follow or Connect with Rodney Moses: Instagram | LinkedIn | YouTube | Donations Patreon | PayPal

    32 min
  3. 26 Jan

    Where To Focus Your Money in MedTech

    Send us a Message In this first MedTech 101 episode of the year, Rodney Moses explores where MedTech is heading in 2026 and beyond. Drawing from industry history, market data, and real-world regulatory experience, he identifies three key growth pillars shaping the future of healthcare: telemedicine, artificial intelligence, and personalised medicine. Using Intuitive Surgical as a case study, Rodney explains how patents, monopolies, and regulation influence innovation and market expansion. He then breaks down why telemedicine is accelerating rapidly, how AI is enhancing (not replacing) clinicians, and why personalised medicine is set to become a trillion-dollar market. This episode offers a clear investment, innovation, and career lens on where MedTech is moving—and where attention should be focused over the next five years. ⏱️ Episode Time-Step Summary (Chapters) (0:00–0:20) High-Growth MedTech Thesis MedTech companies operating in telemedicine, AI, and personalised medicine are positioned for strong long-term growth. (0:20–1:55) Welcome & Podcast Update Rodney Moses welcomes listeners to the first episode of the year, reflects on fewer episodes in 2025, and shares updates on starting postgraduate studies in Munich and expanding the podcast’s scope. (1:55–2:23) Framing the Future of MedTech To predict the future of MedTech, we must first understand the present and recent history of the industry. (2:23–4:08) Intuitive Surgical & Market Evolution Intuitive Surgical’s early patents created a long-lasting monopoly in surgical robotics. Patent expiry enabled competitors, lowered regulatory barriers, and expanded the market. (4:08–4:59) Innovation, Patents & Regulation Discussion on balancing patent protection, innovation incentives, affordability, and the role of regulation in MedTech markets. (4:59–6:35) Telemedicine: Market Growth & Impact Telemedicine as a key future pillar of MedTech, driven by wearables and remote monitoring. Market size: $141B (2024) → $380B (2030)Benefits include hospital decongestion and improved access to care.(6:35–10:00) Artificial Intelligence in MedTech AI as an enabler rather than a replacement for doctors. Use cases include diagnostics, imaging, mental health analysis, and decision support. Market size: $14B (2024) → $255B (2033) Regulatory catch-up remains a challenge, but momentum is strong.(10:06–11:22) Personalised Medicine & Data-Driven Care Shift from generalized treatments to tailored therapies based on individual patient data, improving efficacy and outcomes. (11:22–11:54) Personalised Medicine Market Outlook One of the fastest-growing healthcare markets globally. Market size: $567B (2024) → $1.2T (2033)(11:54–12:57) Where to Focus in MedTech The three strongest growth areas for the next 1–5 years: TelemedicineArtificial IntelligencePersonalised Medicine Surgical robotics remains important but secondary in near-term growth.(12:57–13:11) Closing Remarks Rodney thanks listeners, marks his return to the podcast, and invites guest and topic suggestions. Support the show Follow or Connect with Rodney Moses: Instagram | LinkedIn | YouTube | Donations Patreon | PayPal

    13 min
  4. 25/11/2025

    Revolutionizing Cancer Treatment: The Future of Localized Drug Delivery to Tumors with CEO, Shaun Bagai

    Send us a Message In this compelling episode of MedTech 101, host Rodney Moses sits down with RenovoRx CEO Shaun Bagai to explore the latest breakthroughs in cancer treatment. The conversation opens with a clear-eyed look at the challenges pancreatic cancer patients face, before diving into Shaun’s remarkable journey—from aspiring pre-med student to seasoned medtech leader—and the pivotal role engineering plays in redefining cancer care. Rodney underscores the importance of pairing technological innovation with true patient-centric thinking, setting the tone for an insightful discussion on medtech’s ability to transform lives. Shaun explains how RenovoRx is changing the treatment landscape through its patented localized therapy platform, designed to deliver chemotherapy directly to the tumor while reducing life-limiting systemic side effects. Their discussion highlights the development and impact of the RenovoCath catheter and the Trans-Arterial Micro-Perfusion (TAMP) system, technologies that enable precise, targeted drug delivery and bring renewed hope for improved outcomes. Rodney and Shaun also touch on the contrast between the agility of startups and the slower pace of traditional medtech companies—using RenovoRx’s journey to a NASDAQ listing, without being acquired by a larger player, as a powerful example of strategic independence. The episode wraps with optimism about the future of oncology and the transformative potential of smarter drug-delivery systems. Timestamp Summary 00:00 | Innovative Approach to Treating Pancreatic Cancer Locally 01:50 | Renovo Rx's Innovative Approach to Localized Chemotherapy Delivery 02:31 | From Medtronic to CEO: A Journey in Medical Innovation 05:28 | Leveraging Technology in Medicine for Widespread Impact 06:47 | RenovoRx's Unique Path in the Medtech Industry 12:39 | Innovative Localized Chemotherapy for Pancreatic Cancer Treatment 19:22 | Expanding Life-Saving Technology Beyond the US Market 21:02 | Innovative Delivery Systems for Pancreatic Cancer Treatment Support the show Follow or Connect with Rodney Moses: Instagram | LinkedIn | YouTube | Donations Patreon | PayPal

    24 min
  5. 16/10/2025

    Bioelectronic Medicine: Entering a New Era of Pain Management Without Pills with Dr Kevin Tracey

    Send us a Message Dr Kevin Tracey is a renowned neurosurgeon and the president of the Feinstein Institutes for Medical Research. With over three decades of experience focused on understanding and controlling inflammation. Dr Tracey has pioneered research that led to advancements in bioelectronic medicine. His work explores the potential of the vagus nerve to regulate inflammation, paving the way for innovative treatments for chronic conditions like rheumatoid arthritis. Kevin is also a co-founder of SetPoint Medical, which recently received FDA approval for an implant device aimed at treating inflammation. Timestamp 00:00 Bioelectronic Devices Revolutionize Inflammation Treatment 04:28 Exploring Bioelectronic Medicine and Innovative Medical Research 09:09 Vagus Nerve Stimulation as a Breakthrough in Inflammation Treatment 13:07 Implant Revolutionizes Rheumatoid Arthritis Treatment 15:56 Vagus Nerve Stimulation and Its Role in Inflammation Control 20:25 SetPoint Medical's FDA Approval and Future Distribution Challenges 24:08 The Promise of Vagus Nerve Stimulation for Rheumatoid Arthritis 27:29 Understanding Present Data to Predict Future Technological Advancements 29:48 Vagus Nerve Stimulation as a Future Inflammation Treatment 32:16 Podcast Interview with Author Kevin Tracey Book: The Great Nerve: The New Science of the Vagus Nerve and How to Harness Its Healing Reflexes  Support the show Follow or Connect with Rodney Moses: Instagram | LinkedIn | YouTube | Donations Patreon | PayPal

    32 min

Ratings & Reviews

5
out of 5
4 Ratings

About

Discussions about Medical Technology, Pharmaceuticals and popular trends; covering from basic to complex topics in a simplified way to make you understand. Rodney is a Biomedical Engineer and co-inventor working in R&D, ex Johnson & Johnson.